How valid is the clinical diagnosis of Parkinson's disease in the community? - Wikidata - wikimedia - TriplyDB

How valid is the clinical diagnosis of Parkinson's disease in the community?

How valid is the clinical diagnosis of Parkinson's disease in the community?

http://www.wikidata.org/entity/Q35469936

about

Persistent organochlorine pesticides in serum and risk of Parkinson disease The role of early life environmental risk factors in Parkinson disease: what is the evidence?Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk Elevated synchrony in Parkinson disease detected with electroencephalography The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson's disease symptom severity.Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.Single and dual task gait training in people with Parkinson's disease: a protocol for a randomised controlled trial Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease.Psychiatric aspects of Parkinson's disease.Serum vitamin D and the risk of Parkinson disease.Physical activity and risk of Parkinson's disease: a prospective cohort study Cerebrovascular disease pathology and parkinsonian signs in old age.Associations of Ozone and PM2.5 Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study.Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles Computational approaches for understanding the diagnosis and treatment of Parkinson's disease.Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease Medical Record Review to Differentiate between Idiopathic Parkinson's Disease and Parkinsonism: A Danish Record Linkage Study with 10 Years of Follow-Up.Clinical profile of parkinsonian disorders in the tropics: Experience at Kano, northwestern Nigeria.Biomarkers in Parkinson's disease.Approach to diagnosis of Parkinson disease.Validation of hospital register-based diagnosis of Parkinson's disease.Diagnostic errors in older patients: a systematic review of incidence and potential causes in seven prevalent diseases Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.Geographical difference in Parkinson's disease prevalence within West Scotland.[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.Different diagnostic criteria for Parkinson disease: what are the pitfalls?Monolayer-capped gold nanoparticles for disease detection from breath.Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology.Alpha-Synuclein as a Biomarker for Parkinson's Disease.

P2860

Q23917333-621B4492-2AE5-4E63-8F7C-39BA99F5D362 Q24815642-E9BCF875-FDB4-4C44-ACA0-E79B09AE43BE Q26821835-C84A11F8-070D-47E4-A24A-3BA9D2AF6CE0 Q28391573-F6839EB6-ED39-41E2-9EFD-13347405BBE4 Q28608374-7A82BBFE-6098-46F8-B351-59EF847F3BFE Q28660352-A062B6CE-7D8D-4977-AB3A-2960F2E129AB Q30466792-5CFECA7D-5687-49E1-97DF-A474D80E3237 Q33522059-609E9DCB-C456-4A66-A488-A52662A7F321 Q33698620-ADB568C3-1983-45A9-ABA2-50EFBC3A5E5C Q33760571-03B0E9F2-D99D-47F2-A5A1-127854BC9C91 Q33764504-16DB33F1-1E2C-46F4-8D87-D63E5FB03D07 Q33790729-0640BE43-5BB3-4788-A622-6E7C2EDCEB0F Q33879821-CFF9D736-EC4D-4C6F-B0F2-6F40FDDBE70E Q33972196-9ECFA04D-A8FA-481F-9142-1A6FA21A4377 Q34129577-044A5F06-D217-4AF6-A515-060CC508F45C Q34574771-7F7633AE-2004-43D2-A484-AD55D2E625E9 Q34962536-5A4BE5DF-767C-4BE7-9777-FA6A7C7D57D4 Q35148041-16A8A3C9-863E-40AB-B439-538345425E62 Q35448970-48824274-FF9C-4493-BE3E-F8EF9685EF47 Q35597397-FB00E984-8BAC-45D3-B13E-528CBB7C5BE3 Q35726821-6B4F6A0E-C52E-4B56-8A7F-1F532B7EE0CE Q36015547-AB0B3A89-65A3-47F7-9016-0FA73E05816B Q36056735-A5029F67-7BDD-44EB-B923-D1F22166C738 Q36305781-B4A41B25-18DD-436F-8DD3-56477647D642 Q36371466-033A7367-4F7B-42EA-8510-D4F74A456A58 Q36378714-0B4BC58E-9CD8-45A8-A7D2-CB816AE8A515 Q36420314-96D9662D-8CDB-42E7-828F-47D0A79A8363 Q36511295-67374694-199B-4687-8872-BD58B7F6CBBD Q36558596-375752D3-A55F-4807-A3FD-0BCAB8CE136D Q36815107-6A36B00B-5833-48AE-84C9-30C4A8A15432 Q36940073-935C18C9-97BD-4A47-932E-CD816AE73962 Q37267591-5559192A-7F7C-4EB2-A93D-D06054AFF88D Q37313955-D622876C-B6D1-4CBD-8103-BFD98275F98C Q37330245-729E609D-23F9-41F9-8F72-7CDAAEAAC21B Q37853646-BA3EC0B5-E818-4B1B-BC4F-1E8DFC5D5589 Q37910636-B57D5CF0-C5B7-453A-A796-B2CD819E2B67 Q38089628-05210FD8-B380-4E61-833C-1A94BE258AB2 Q38262547-28149B6D-BF48-4F7B-81C7-619803337EB4 Q38732228-455AAFB3-413C-43F4-B0C5-50F0DCBEC027 Q38759482-40A7E2D8-E252-4BE7-BC8F-A4354E02D671

P2860

How valid is the clinical diagnosis of Parkinson's disease in the community?

http://www.wikidata.org/entity/Q35469936

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

How valid is the clinical diagnosis of Parkinson's disease in the community?

@ast

How valid is the clinical diagnosis of Parkinson's disease in the community?

@en

type

label

How valid is the clinical diagnosis of Parkinson's disease in the community?

@ast

How valid is the clinical diagnosis of Parkinson's disease in the community?

@en

prefLabel

How valid is the clinical diagnosis of Parkinson's disease in the community?

@ast

How valid is the clinical diagnosis of Parkinson's disease in the community?

@en

P1433

Q35469936-3A972039-665B-4CAA-9CA9-331A06390B21

P1476

Q35469936-4A351E90-5073-4901-A5E2-FFCD457A5B75

P2093

Q35469936-076D39A7-EC31-4C5E-A6C2-8EAAA359E3DF

Q35469936-AF55C387-95FD-4A09-A3A0-0DA639FE0602

Q35469936-B45C6C7C-7207-4925-A00A-5191C7EE3058

P2860

Q35469936-130E4A6E-171B-45F2-BA96-E4F7315F3167

Q35469936-17F7CAAA-70FB-4492-A657-A6EB69ECE7DD

Q35469936-4307384D-B4E6-4900-9922-3F88A80F434C

Q35469936-471B4EF8-7337-456D-A608-955F4F424723

Q35469936-4EE83BC3-2A79-4136-BC0F-DD4B8EC34929

Q35469936-542A9E1E-0750-45F3-8BAE-C4C7BDF35650

Q35469936-5F61C75C-C5BD-418B-88B4-3022D32CE8CC

Q35469936-7387FBFA-78E2-4F46-8A9A-98C049283B2F

Q35469936-91A88E13-B02A-4C75-AA26-F741FD02BC9B

Q35469936-C562A518-80A0-42AE-A594-DD611A93EF94

P304

Q35469936-B3270C0D-66A1-4260-9488-7BBCEBC6E1E8

P31

Q35469936-83A569A6-48B6-4835-AD05-FDAF9D5A57C7

P356

Q35469936-4D347352-8EDD-4634-9BD8-87DCEF90E09B

P407

Q35469936-49EABC7B-29DD-404B-A9F2-B9F26FEC2AF4

P433

Q35469936-7946B689-5498-4107-A072-C0E1CBEA7CF1

P478

Q35469936-9703498A-04F4-49C6-A41A-84564806DD8E

P577

Q35469936-8C2143C0-671A-44FD-A2F2-2729E707FDD6

P5875

Q35469936-9B20FB87-74AF-4444-B09F-2C18E0559846

P698

Q35469936-F5A54BC6-344D-4808-9089-F09BC74B888D

P921

Q35469936-5D0E8CAD-AE8D-4253-A0CA-94C7CBA399C0

P932

Q35469936-091AC29D-B580-4FF2-BC40-38AA3AF901D0

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

How valid is the clinical diagnosis of Parkinson's disease in the community?

@en

P2093

A Schrag

http://www.w3.org/2001/XMLSchema#string

N Quinn

http://www.w3.org/2001/XMLSchema#string

Y Ben-Shlomo

http://www.w3.org/2001/XMLSchema#string

P2860

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Multiple system atrophy--the nature of the beast.

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.

Parkinson's disease in a Scottish city.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Epidemiology of Parkinson's disease in Finland.

The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.

Accuracy of clinical diagnosis in parkinsonism--a prospective study.

Sedimentation level in acute intracerebral hematoma in a patient receiving anticoagulation therapy: an autopsy study.

P304

529-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.73.5.529

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10704319

http://www.w3.org/2001/XMLSchema#string

P698

12397145

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

1738115

http://www.w3.org/2001/XMLSchema#string